Swedish company pioneering immuno-oncology with an entirely novel, proprietary treatment concept that restores the immune system in cancer – now approved by the Swedish MPA for a First-in-Man cancer trial.
VISIT SITECanImGuide
Keiretsu Forum NordicsPortfolio, Portfolio company
Swedish company pioneering immuno-oncology with an entirely novel, proprietary treatment concept that restores the immune system in cancer – now approved by the Swedish MPA for a First-in-Man cancer trial.
VISIT SITE